This country will allow psychedelics for depression treatment from today, a 1st | World News - Hindustan Times
close_game
close_game

This country will allow psychedelics for depression treatment from today, a first

Jul 01, 2023 04:00 AM IST

Australia's drug watchdog Therapeutic Goods Administration (TGA) approved the move after almost three years of deliberation.

Australia has become the world's first country to allow doctors to prescribe MDMA and magic mushrooms to treat as depression and Post Trauma Stress Disorder (PTSD). The controversial move came into force today but was taken in February earlier this year. Australia's drug watchdog Therapeutic Goods Administration (TGA) approved the move after almost three years of deliberation and consultation with experts. Although, authorities said that they will continue to closely monitor the cases.

Australia's drug watchdog approved the move.(Representational)
Australia's drug watchdog approved the move.(Representational)

What is MDMA and magic mushrooms?

MDMA is a synthetic drug which is also called "molly" or “ecstasy”. Magic mushrooms are known for giving an excessively trippy experience to the user due to the presence of “psilocybin”. Both drugs are "prohibited substances" currently and are used in closely controlled clinical trials in Australia.

HT launches Crick-it, a one stop destination to catch Cricket, anytime, anywhere. Explore now!

Read more: Sue Johanson dies at 93: All you need to know about the Canadian sex expert

Advocates of the decision believe that the drug can also be used for treating eating disorders, alcohol dependence and obsessive-compulsive disorder.

What do critics of the move say?

Critics are concerned that there is insufficient research to show that the drugs are helpful in treating depression and PTSD.

"It’s not for everybody. We need to work out who these people are that are going to have bad experiences, and not recommend it,” Susan Rossell, a psychiatrist at Swinburne University of Technology, Melbourne told Nature.

“Instead, it seems the TGA has yielded to pressure from the public and lobby groups to increase access to these experimental treatments, outside of clinical trials. Sufficient levels of evidence have not yet been generated for broad-scale implementation to be justified," the expert said.

Discover the complete story of India's general elections on our exclusive Elections Product! Access all the content absolutely free on the HT App. Download now!

Get Latest World News, along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
  • ABOUT THE AUTHOR
    author-default-90x90

    When not reading, this ex-literature student can be found searching for an answer to the question, "What is the purpose of journalism in society?"

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Sunday, April 21, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On